Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA;BCDAW · Entity 7752 | Vice President of Operations | June 30, 2020 | July 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date June 30, 2020 · Filed July 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,867 |
Reported balance
After 2020-06-30 transaction · row 1
1 source rowRow 1 · 2020-06-30 · Tax withholding · Disposed 6,185 · Balance 11,867 F1: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2020 Filed Jul 2, 2020 01:15 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 6,185 | $2.40 | $14,844.00 |
DisclosureSEC source: 0001437749-20-014422 · rdgdoc.xml · nonDerivative · entry 1 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,867 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 23:19 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001437749-20-008735 · rdgdoc.xml · derivative · entry 2 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-24 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on May 24, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 23:19 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 15,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-008735 · rdgdoc.xml · nonDerivative · entry 1 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,052 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020. Read SEC document |
| March 11, 2020 Filed Mar 28, 2020 01:56 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 2,023 | $3.60 | $7,282.80 |
DisclosureSEC source: 0001437749-20-006392 · rdgdoc.xml · nonDerivative · entry 2 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,924 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4. Read SEC document |
| August 27, 2019 Filed Mar 28, 2020 01:56 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-006392 · rdgdoc.xml · nonDerivative · entry 1 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,947 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on January 29, 2020. F2 · balance_after: This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4. Read SEC document |
| February 01, 2018 Filed Mar 22, 2018 18:24 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001437749-18-005232 · rdgdoc.xml · derivative · entry 1 Pesta Phil · CIK 0001686095 · Vice President of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common stock · 70,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.